Exact Sciences Corp (EXAS)

17.38
NASDAQ : Health Care
Prev Close 17.32
Day Low/High 16.84 / 17.64
52 Wk Low/High 4.67 / 24.74
Avg Volume 5.43M
Exchange NASDAQ
Shares Outstanding 98.33M
Market Cap 1.70B
EPS -1.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Exact Sciences (EXAS) Stock Falling After Public Offering

Exact Sciences (EXAS) Stock Falling After Public Offering

Exact Sciences (EXAS) announced today that it would be offering 8.5 million shares of common stock.

Exact Sciences Announces Agreement To Sell 7,000,000 Common Shares

Exact Sciences Announces Agreement To Sell 7,000,000 Common Shares

Exact Sciences Corporation (NASDAQ: EXAS) today announced an agreement to sell 7,000,000 shares of its common stock to Jefferies LLC, Robert W.

Strong On High Relative Volume: Exact (EXAS)

Strong On High Relative Volume: Exact (EXAS)

Trade-Ideas LLC identified Exact (EXAS) as a strong on high relative volume candidate

Exact Sciences (EXAS) Stock Soars on Q2 Earnings Beat

Exact Sciences (EXAS) Stock Soars on Q2 Earnings Beat

Exact Sciences (EXAS) is climbing today after the company reports better-than-expected 2016 second quarter earnings.

9-Day Churn Favors Upside Resolution

9-Day Churn Favors Upside Resolution

Tomorrow's FOMC decision is a convenient catalyst for a move.

NCQA Proposes Inclusion Of Cologuard In 2017 HEDIS Quality Measures

NCQA Proposes Inclusion Of Cologuard In 2017 HEDIS Quality Measures

Updated HEDIS Measures Would Align with Final USPSTF Recommendations

Trade-Ideas: Exact (EXAS) Is Today's Post-Market Leader Stock

Trade-Ideas: Exact (EXAS) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Exact (EXAS) as a post-market leader candidate

Exact Sciences (EXAS) Stock Rising on Illumina Takeover Speculation

Exact Sciences (EXAS) Stock Rising on Illumina Takeover Speculation

Shares of Exact Sciences (EXAS) are gaining after reports that the company may be acquired by Illumina (ILMN).

Exact (EXAS) Is Weak On High Volume Today

Exact (EXAS) Is Weak On High Volume Today

Trade-Ideas LLC identified Exact (EXAS) as a weak on high relative volume candidate

5 Hot Stocks to Watch Right Now

5 Hot Stocks to Watch Right Now

Biotech stocks continue to dominate our top stock charts to watch.

Exact (EXAS) Highlighted As Today's Perilous Reversal Stock

Exact (EXAS) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Exact (EXAS) as a "perilous reversal" (up big yesterday but down big today) candidate

Exact (EXAS) Marked As A Dead Cat Bounce Stock

Exact (EXAS) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Exact (EXAS) as a "dead cat bounce" (down big yesterday but up big today) candidate

Perilous Reversal Watch: Exact (EXAS)

Perilous Reversal Watch: Exact (EXAS)

Trade-Ideas LLC identified Exact (EXAS) as a "perilous reversal" (up big yesterday but down big today) candidate

Exact (EXAS) Is Today's Strong On High Volume Stock

Exact (EXAS) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Exact (EXAS) as a strong on high relative volume candidate

7 Stocks Trading on Big Volume -- but What Do the Charts Say?

7 Stocks Trading on Big Volume -- but What Do the Charts Say?

Here's a technical look at how to trade seven of the most active stocks on the market right now.

One Reason Why EXACT Sciences (EXAS) Stock Is Up Today

One Reason Why EXACT Sciences (EXAS) Stock Is Up Today

A new recommendation statement from the USPSTF boosts EXACT Sciences (EXAS) outlook and led to Canaccord Genuity raising their price target.

Exact (EXAS): Heavy Pre-Market Activity

Exact (EXAS): Heavy Pre-Market Activity

Trade-Ideas LLC identified Exact (EXAS) as a pre-market mover with heavy volume candidate

EXAS: Insiders vs. Shorts

EXAS: Insiders vs. Shorts

The most recent short interest data was recently released for the 03/31/2016 settlement date, and EXACT Sciences Corp. is one of the most shorted stocks of the Russell 3000, based on 11.71 "days to cover" versus the median component at 5.75.

Cologuard Available In-Network For Anthem Blue Cross And Blue Shield Members In Five Additional Midwest States

Cologuard Available In-Network For Anthem Blue Cross And Blue Shield Members In Five Additional Midwest States

Exact Sciences Completes Contracting with Anthem Commercial and Medicare Advantage Plans in Ind., Ohio, Ky., Mo. and Wis.

'Mad Money' Lightning Round: Stay Away From BP

'Mad Money' Lightning Round: Stay Away From BP

Cramer prefers Whole Foods over Kroger and thinks Ford is terrific.

Jim Cramer's 'Mad Money' Recap: This Market Is Rising No Matter What You Think

Jim Cramer's 'Mad Money' Recap: This Market Is Rising No Matter What You Think

Some people can't accept that things are improving, but that means the market will continue to go higher, Cramer says.